BioSpace News Archive

The decision was based on new analysis run by Biogen in consultation with the FDA of a larger dataset from the trials halted in March.

The key to retaining your employees is to keep them happy and fulfilled in their positions, but what is important to one person can be vastly different than that of another. So how do you retain your top talent?

Researchers at UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology & Neurosurgery are set to test whether a drug can slow progression of the devastating neurodegenerative condition Multiple System Atrophy

The U.S. Food and Drug Administration approved a new cystic fibrosis medication that is expected to provide treatment for 90% of patients with this debilitating and life-shortening condition.

Here’s a look at five biotech and pharmaceutical innovation trends from 2019.

Regenstrief Institute research scientist Theresa Cullen, M.D., has won a Leading for Impact, Women in Leadership award.

The French company PhinC Development, specialized in simulation and modeling strategy for drug development, strengthens its presence in North America to significantly develop its business and increase its turnover.

Just a few weeks after celebrating the treatment of its 3,000th pet, national pet cancer care provider PetCure Oncology presented data suggesting that advanced radiation therapy delivered within PetCure-developed treatment protocols is leading to better survival outcomes than other treatment options for at least nine specific tumor types.

APEIRON Biologics AG announced that it will present preclinical data for its clinical stage project APN401 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 26-30 October 2019 in Boston, MA, USA.

The theme of the 2019 World Congress of Neurology (WCN 2019), Accelerating the Pace of Change, emphasizes the global effort to further neurological healthcare, and serves as a springboard to advance the field of neurology around the globe.